Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines

Exploring the Geometry of Treatment Networks

(2013) Georgia Salanti et al.   ANNALS OF INTERNAL MEDICINE

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

(2012) Laurent Coudeville et al.   BMC Medical Research Methodology

Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials

(2011) François Roman et al.   Clinical and Vaccine Immunology

Immunogenicity and safety of a novel AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan

(2011) Hideyuki Ikematsu et al.   Human vaccines & immunotherapeutics

Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age

(2011) Adriano Arguedas et al.   Human vaccines & immunotherapeutics

Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China

(2011) Xiao-Feng Liang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Influenza A (H1N1) 2009 two-dose immunization of US children: An observer-blinded, randomized, placebo-controlled trial

(2011) Eric Plennevaux et al.   VACCINE

Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents

(2011) Susanna Esposito et al.   VACCINE

Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children

(2010) Yuji Yasuda et al.   ADVANCES IN THERAPY

Immunogenicity Associated with the Routine Use of an Influenza A H1N1 Vaccine in Health Care Personnel in Guangzhou, China

(2010) B. Di et al.   Clinical and Vaccine Immunology

AS03A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age

(2010) François Roman et al.   CLINICAL INFECTIOUS DISEASES

Panvax®: a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009

(2010) Jodie McVernon et al.   Expert Review of Vaccines

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

(2010) Georgia Salanti et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

A Rapid Immune Response to 2009 Influenza A(H1N1) Vaccines in Adults: A Randomized, Double‐Blind, Controlled Trial

(2010) Jiang Wu et al.   JOURNAL OF INFECTIOUS DISEASES

A Single Dose of Unadjuvanted Novel 2009 H1N1 Vaccine Is Immunogenic and Well Tolerated in Young and Elderly Adults

(2010) Kawsar R. Talaat et al.   JOURNAL OF INFECTIOUS DISEASES

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

(2010) Karl G Nicholson et al.   LANCET INFECTIOUS DISEASES

Evaluation of Adjuvanted Pandemic H1N12009 Influenza Vaccine After One and Two Doses in Young Children

(2010) David W. Scheifele et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials

(2010) Raburn M. Mallory et al.   PLoS One

Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine

(2010) Yizhuo Sun et al.   PLoS One

Checking consistency in mixed treatment comparison meta-analysis

(2010) S. Dias et al.   STATISTICS IN MEDICINE

Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to

(2010) Chi-Eun Oh et al.   VACCINE

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010

(2010) Claudia Vellozzi et al.   VACCINE

A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza

(2010) Hsiang-Chi Kung et al.   VACCINE

Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly

(2010) Tsui Mai Kao et al.   VACCINE

The 2009 A (H1N1) influenza virus pandemic: A review

(2010) Marc P. Girard et al.   VACCINE

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents

(2010) Chun-Yi Lu et al.   VACCINE

An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers

(2010) Abdullah S. Madhun et al.   VACCINE

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months

(2010) Alfonso Carmona et al.   VACCINE

Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea

(2010) Hee Jin Cheong et al.   VACCINE

Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine

(2010) Day-Yu Chao et al.   VACCINE

Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study

(2010) M. Loebermann et al.   VACCINE

Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses

(2009) J. P.A. Ioannidis   CANADIAN MEDICAL ASSOCIATION JOURNAL

Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria™) in adult and elderly subjects

(2009) R. Gasparini et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children

(2009) Terry Nolan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Large trials confirm immunogenicity of H1N1 vaccines

(2009) Heath Kelly et al.   LANCET

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials

(2009) Eric Plennevaux et al.   LANCET

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial

(2009) Xiao-Feng Liang et al.   LANCET

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009–10 influenza season: a multicentre, randomised controlled trial

(2009) Zoltan Vajo et al.   LANCET

Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis

(2009) Lamberto Manzoli et al.   LANCET INFECTIOUS DISEASES

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine

(2009) Michael E. Greenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Influenza A (H1N1) Vaccine in Various Age Groups

(2009) Feng-Cai Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine

(2009) Tristan W. Clark et al.   NEW ENGLAND JOURNAL OF MEDICINE

Responses to 2009 H1N1 Vaccine in Children 3 to 17 Years of Age

(2009) Adriano Arguedas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial

(2009) François Roman et al.   VACCINE